FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leo Verdonck

Research Profile

Procedures

Disorders

Concepts & Ideas

Phenomena

Recurrence

Anatomy

T-Lymphocytes

Co-author Network

Publications

TOP 3
Stefan Gröschel; Marije Havermans; Jürgen Krauter; Michael W M Kühn; Bob Löwenberg; Michael Lübbert; Gert J Ossenkoppele; Thomas Pabst; Veronika Rockova; Brigitte Schlegelberger; Richard F Schlenk; Ingo G H Schmidt-Wolf; Gerrit J Schuurhuis; Veronica Teleanu; Peter J M Valk; Peter Vandenberghe; Edo Vellenga; Leo F Verdonck; Gregor Verhoef; Hartmut Döhner; Konstanze Döhner; Karina Eiwen; Jan Engelmann; Claudia Erpelinck; Arnold Ganser; Ulrich Germing; Mario Bargetzi; Berna Beverloo; Ruud Delwel
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Johanna C Ham; Judith M Hoogendijk-van den Akker; Leo F Verdonck
A hemodialysis patient with higher-risk myelodysplastic syndrome treated with standard-dose azacitidine.
Jan J Cornelissen; Alois A Gratwohl; Berna Beverloo; Bart J Biemond; Dimitri Breems; Johan Maertens; Gert J Ossenkoppele; Thomas Pabst; Jakob R Passweg; Marinus van Marwijk Kooy; Wim L J van Putten; Edo Vellenga; Leo F Verdonck; Pierre W Wijermans; Bob Löwenberg
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leo Verdonck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stefan Gröschel; Marije Havermans; Jürgen Krauter; Michael W M Kühn; Bob Löwenberg; Michael Lübbert; Gert J Ossenkoppele; Thomas Pabst; Veronika Rockova; Brigitte Schlegelberger; Richard F Schlenk; Ingo G H Schmidt-Wolf; Gerrit J Schuurhuis; Veronica Teleanu; Peter J M Valk; Peter Vandenberghe; Edo Vellenga; Leo F Verdonck; Gregor Verhoef; Hartmut Döhner; Konstanze Döhner; Karina Eiwen; Jan Engelmann; Claudia Erpelinck; Arnold Ganser; Ulrich Germing; Mario Bargetzi; Berna Beverloo; Ruud Delwel
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):95-103.
2012: Johanna C Ham; Judith M Hoogendijk-van den Akker; Leo F Verdonck
A hemodialysis patient with higher-risk myelodysplastic syndrome treated with standard-dose azacitidine.
Leukemia & lymphoma 2012;53(12):2521-2.
2012: Jan J Cornelissen; Alois A Gratwohl; Berna Beverloo; Bart J Biemond; Dimitri Breems; Johan Maertens; Gert J Ossenkoppele; Thomas Pabst; Jakob R Passweg; Marinus van Marwijk Kooy; Wim L J van Putten; Edo Vellenga; Leo F Verdonck; Pierre W Wijermans; Bob Löwenberg
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(17):2140-6.
2012: Janneke C Ham; Jeroen J W M Janssen; Philip M Kluin; James E Boers; Leo F Verdonck
Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(8):e102-3.
2012: Salut Brunet; Jan Cornelissen; Jordi Esteve; Alois Gratwohl; Anna P Iori; Myriam Labopin; Mohamad Mohty; Jorge Sierra; Gerard Socié; Leo F Verdonck; Liisa Volin; Vanderson Rocha
Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):735-41.
2011: T Lodewyck; Bob Lowenberg; E Meijer; M Oudshoorn; E Petersen; A V M B Schattenberg; E Spierings; B van der Holt; Leo F Verdonck; P A von dem Borne; Rein Willemze; Wil Allebes; L Duinhouwer; M Groenendijk-Sijnke; Jan J Cornelissen
Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.
Leukemia 2011;25(10):1548-54.
2011: Hanneke M van der Straaten; Nan van Geloven; Leo F Verdonck; Martine M Paquay; Marcel G J Tilanus; Cynthia Huisman
NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(8):1231-6.
2011: Bob Löwenberg; Thomas Pabst; Edo Vellenga; Wim L J van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Bart J Biemond; Alois Gratwohl; Georgine E De Greef; Leo F Verdonck; M Ronald Schaafsma; Michael Gregor; Matthias Theobald; Urs Schanz; Johan Maertens; Gert Ossenkoppele
Cytarabine dose for acute myeloid leukemia.
The New England journal of medicine 2011;364(11):1027-36.
2011: Nazik Rayman; King H Lam; Bronno van der Holt; Clara Koss; Dennis Veldhuizen; Leo M Budel; Andries H Mulder; Leo F Verdonck; Ruud Delwel; Daphne de Jong; Gustaaf W van Imhoff; Pieter Sonneveld
Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trials.
Clinical lymphoma, myeloma & leukemia 2011;11(1):23-32.
2010: Wendy Deenik; J J W M Janssen; Bronno van der Holt; Gregor Verhoef; Willem M Smit; Marie José Kersten; Simon M G J Daenen; Leo F Verdonck; Augustin Ferrant; A V M B Schattenberg; Pieter Sonneveld; Marinus van Marwijk Kooy; Shulamiet Wittebol; Roelof Willemze; Pierre W Wijermans; Berna Beverloo; Bob Löwenberg; Peter J M Valk; Gert Ossenkoppele; Jan J Cornelissen
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.
Haematologica 2010;95(6):914-21.
2010: Stefan Gröschel; Sanne Lugthart; Richard F Schlenk; Peter J M Valk; Karina Eiwen; Chantal Goudswaard; Wim J L van Putten; Sabine Kayser; Leo F Verdonck; Michael Lübbert; Gert-Jan Ossenkoppele; Ulrich Germing; Ingo Schmidt-Wolf; Brigitte Schlegelberger; Jürgen Krauter; Arnold Ganser; Hartmut Döhner; Bob Löwenberg; Konstanze Döhner; Ruud Delwel
High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):2101-7.
2010: Bob Löwenberg; Joachim Beck; Carlos Graux; Wim van Putten; Harry C Schouten; Leo F Verdonck; Augustin Ferrant; Pieter Sonneveld; Mojca Jongen-Lavrencic; Marie von Lilienfeld-Toal; Bart J Biemond; Edo Vellenga; Dimitri Breems; Hilde de Muijnck; Ron Schaafsma; Gregor Verhoef; Hartmut Döhner; Alois Gratwohl; Thomas Pabst; Gert Ossenkoppele; Johan Maertens
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study.
Blood 2010;115(13):2586-91.
2010: Mariëlle M J Beckers; Leo F Verdonck; Jan J Cornelissen; A V M B Ton Schattenberg; Jeroen J W M Janssen; Ron Willemze; Gustaaf W van Imhoff; J Hans van der Lelie; Pierre W Wijermans; Ron Schaafsma; Joke Baars; M Rien van Marwijk Kooij; Douwe H Biesma; Anja van Biezen; Ronald Brand; Harry C Schouten
[Autologous stem cell transplantation in haematological disorders,1980-2002].
Nederlands tijdschrift voor geneeskunde 2010;154():A2025.
2009: Irit Avivi; Silvia Montoto; Carme Canals; John Maertens; Haifa Al-Ali; Ghulam J Mufti; Jürgen Finke; Anton Schattenberg; Renato Fanin; Jan J Cornelissen; Jean-Paul Vernant; Nigell Russell; Yves Beguin; Kirsty Thomson; Leo F Verdonck; Guido Kobbe; Herve Tilly; Gerard Socié; Anna Sureda
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
British journal of haematology 2009;147(5):719-28.
2009: Bob Löwenberg; Gert Ossenkoppele; Wim L J van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Johan Maertens; Mojca Jongen-Lavrencic; Marie von Lilienfeld-Toal; Bart J Biemond; Edo Vellenga; Marinus van Marwijk Kooy; Leo F Verdonck; Joachim Beck; Hartmut Döhner; Alois Gratwohl; Thomas Pabst; Gregor Verhoef
High-dose daunorubicin in older patients with acute myeloid leukemia.
The New England journal of medicine 2009;361(13):1235-48.
2009: Suzanne van Dorp; Floor Pietersma; Matthias Wölfl; Leo F Verdonck; Eefke J Petersen; Henk M Lokhorst; Edwin Martens; Matthias Theobald; Debbie Van Baarle; Ellen Meijer; Jürgen Kuball
Rituximab treatment before reduced-intensity conditioning transplantation associates with a decreased incidence of extensive chronic GVHD.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):671-8.
2009: A V M B Schattenberg; Harry C Schouten; Leo F Verdonck; Roel Willemze; J van der Lelie; Peter C Huijgens; Gustaaf W van Imhoff; Anja van Biezen; Ronald Brand; A Hagenbeek; Theo de Witte; Jan J Cornelissen
[Allogenic stem cell transplantation in the Netherlands].
Nederlands tijdschrift voor geneeskunde 2009;153(9):380-5.
2009: Jan J Cornelissen; Bronno van der Holt; Gregor Verhoef; Mars B van't Veer; Marinus H J van Oers; Harry C Schouten; Gert Ossenkoppele; Pieter Sonneveld; Johan Maertens; Marinus van Marwijk Kooy; M Ronald Schaafsma; Pierre W Wijermans; Douwe H Biesma; Shulamiet Wittebol; Paul J Voogt; Joke W Baars; Pierre Zachée; Leo F Verdonck; Bob Löwenberg; Adriaan W Dekker
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Blood 2009;113(6):1375-82.
2008: Sabina Kersting; Leo F Verdonck
Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1312-6.
2008: M Loes van Kempen-Harteveld; Ronald Brand; Henk B Kal; Leo F Verdonck; Pieter Hofman; A V M B Schattenberg; Richard W van der Maazen; Jan J Cornelissen; Wil M H Eijkenboom; Johannes P van der Lelie; Foppe Oldenburger; Renée M Y Barge; Anja van Biezen; Jaak M Vossen; Evert M Noordijk; Henk Struikmans
Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
International journal of radiation oncology, biology, physics 2008;71(5):1444-54.
2008: Tineke Aarts-Riemens; Maarten E Emmelot; Leo F Verdonck; Tuna Mutis
Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
European journal of immunology 2008;38(5):1381-90.
2008: Sabina Kersting; Leo F Verdonck
Chronic kidney disease after nonmyeloablative stem cell transplantation in adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):403-8.
2008: Thomas C Kwee; Robert M Kwee; Leo F Verdonck; Marc Bierings; Rutger A J Nievelstein
Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma.
British journal of haematology 2008;141(1):60-8.
2008: Jennifer Schellekens; Erik H Rozemuller; Eefke J Petersen; Jan G van den Tweel; Leo F Verdonck; Marcel G J Tilanus
Activating KIRs exert a crucial role on relapse and overall survival after HLA-identical sibling transplantation.
Molecular immunology 2008;45(8):2255-61.
2008: Wendy Deenik; Bronno van der Holt; Gregor Verhoef; Willem M Smit; Marie J Kersten; Hanneke C Kluin-Nelemans; Leo F Verdonck; Augustin Ferrant; A V M B Schattenberg; Jeroen J W M Janssen; Pieter Sonneveld; Marinus van Marwijk Kooy; Shulamiet Wittebol; Roelof Willemze; Pierre W Wijermans; Petra H M Westveer; Berna Beverloo; Peter Valk; Bob Löwenberg; Gert Ossenkoppele; Jan J Cornelissen
Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.
Blood 2008;111(5):2581-8.
2008: Roel A de Weger; I Verbrugge; Annette H Bruggink; M M van Oosterhout; Y de Souza; Dick F van Wichen; Frits H J Gmelig-Meyling; Nicolaas de Jonge; Leo F Verdonck
Stem cell-derived cardiomyocytes after bone marrow and heart transplantation.
Bone marrow transplantation 2008;41(6):563-9.
2008: Cynthia Huisman; Ellen Meijer; Eefke J Petersen; Henk M Lokhorst; Leo F Verdonck
Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):181-6.
2008: Jennifer Schellekens; Erik H Rozemuller; Eefke J Petersen; Jan G van den Tweel; Leo F Verdonck; Marcel G J Tilanus
Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation.
Molecular immunology 2008;45(4):981-9.
2008: Edo Vellenga; Wim L J van Putten; Mars B van 't Veer; Josée M Zijlstra; Willem E Fibbe; Marinus H J van Oers; Leo F Verdonck; Pierre W Wijermans; Gustaaf W van Imhoff; Pieternella J Lugtenburg; Peter C Huijgens
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Blood 2008;111(2):537-43.
2008: Sabina Kersting; Suzanne V Dorp; Matthias Theobald; Leo F Verdonck
Acute renal failure after nonmyeloablative stem cell transplantation in adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):125-31.
2007: Gösta Gahrton; Simona Iacobelli; Giuseppe Bandini; Bo Björkstrand; Paolo Corradini; Charles Crawley; Ute Hegenbart; Gareth Morgan; Nicolaus Kröger; Anton Schattenberg; Stefan O Schönland; Leo F Verdonck; Liisa Volin; Theo de Witte; Dietger Niederwieser
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
Haematologica 2007;92(11):1513-8.
2007: Sabina Kersting; Ronald J Hené; Hein A Koomans; Leo F Verdonck
Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1169-75.
2007: Sabina Kersting; Leo F Verdonck
Stem cell transplantation nephropathy: a report of six cases.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):638-43.
2007: Alexander Greb; Julia Bohlius; Sven Trelle; Daniel Schiefer; Carmino Antonio De Souza; Christian Gisselbrecht; Tanin Intragumtornchai; Ulrich Kaiser; Hanneke C Kluin-Nelemans; Maurizio Martelli; Noel Jean Milpied; Gino Santini; Leo F Verdonck; Umberto Vitolo; Guido Schwarzer; Andreas Engert
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis.
Cancer treatment reviews 2007;33(4):338-46.
2007: S van Dorp; Ellen Meijer; Niels W C J van de Donk; Adriaan W Dekker; K Nieuwenhuis; Monique C Minnema; E Petersen; Roger Schutgens; Leo F Verdonck; Henk M Lokhorst
Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced.
The Netherlands journal of medicine 2007;65(5):178-84.
2007: Jan J Cornelissen; Wim L J van Putten; Leo F Verdonck; Matthias Theobald; Emanuel Jacky; S M G J Daenen; Marinus van Marwijk Kooy; Pierre W Wijermans; Harry Schouten; Peter C Huijgens; Hans van der Lelie; Martin Fey; Augustin Ferrant; Johan Maertens; Alois Gratwohl; Bob Lowenberg
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Blood 2007;109(9):3658-66.
2007: Ymkje M Hettinga; Leo F Verdonck; Rob Fijnheer; Ger T Rijkers; Aniki Rothova
Anterior uveitis: a manifestation of graft-versus-host disease.
Ophthalmology 2007;114(4):794-7.
2007: Leo F Verdonck; Annelise Notenboom; Daphne D de Jong; Marius A Mackenzie; Gregor Verhoef; Mark H H Kramer; Gert Ossenkoppele; Jeanette K Doorduijn; Pieter Sonneveld; Gustaaf W van Imhoff
Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON).
Blood 2007;109(7):2759-66.
2007: S Kersting; H A Koomans; Ronald J Hené; Leo F Verdonck
Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival.
Bone marrow transplantation 2007;39(6):359-65.
2007: C Huisman; Roel A de Weger; L de Vries; Marcel G J Tilanus; Leo F Verdonck
Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.
Bone marrow transplantation 2007;39(5):285-91.
2007: W Deenik; Bronno van der Holt; Gregor Verhoef; A V M B Schattenberg; Leo F Verdonck; S M G J Daenen; Pierre Zachée; Petra H M Westveer; W M Smit; Shulamiet Wittebol; Harry C Schouten; Bob Löwenberg; Gert Ossenkoppele; Jan J Cornelissen
High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.
Annals of hematology 2007;86(2):117-25.
2006: C Huisman; Hanneke M van der Straaten; Marijke R Canninga-Van Dijk; Rob Fijnheer; Leo F Verdonck
Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease.
Bone marrow transplantation 2006;38(8):561-6.
2006: Tuna Mutis; Rozemarijn S van Rijn; Elles R Simonetti; Tineke Aarts-Riemens; Maarten E Emmelot; Louis van Bloois; Anton Martens; Leo F Verdonck; Saskia B Ebeling
Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5520-5.
2006: Gustaaf W van Imhoff; Evert-Jan G Boerma; Bronno van der Holt; Ed Schuuring; Leo F Verdonck; Hanneke C Kluin-Nelemans; Philip M Kluin
Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4135-42.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2006;37(12):1135-41.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Blood 2006;107(8):3415-6.
2006: Hanna J Khoury; Fausto R Loberiza; Olle Ringdén; A John Barrett; Brian J Bolwell; Jean-Yves Cahn; Richard E Champlin; Robert Peter Gale; gregory alan hale; Alvaro Urbano-Ispizua; Rodrigo Martino; Philip L McCarthy; Pierre Tiberghien; Leo F Verdonck; Mary M Horowitz
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
Blood 2006;107(4):1712-6.
2005: Tuna Mutis; Tineke Aarts-Riemens; Leo F Verdonck
The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Haematologica 2005;90(10):1389-95.
2005: Hanneke M van der Straaten; Anja van Biezen; Ronald Brand; A V M B Schattenberg; Roel M Egeler; Renée M Y Barge; Jan J Cornelissen; Harry C Schouten; Gert Ossenkoppele; Leo F Verdonck
Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
Haematologica 2005;90(10):1339-45.
2005: Gustaaf W van Imhoff; Bronno van der Holt; Marius A Mackenzie; Mars B van't Veer; Pierre W Wijermans; Gert Ossenkoppele; Harry C Schouten; Pieter Sonneveld; Monique M C Steijaert; Philip M Kluin; Hanneke C Kluin-Nelemans; Leo F Verdonck
Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3793-801.
2005: Gustaaf W van Imhoff; Bronno van der Holt; Marius A Mackenzie; Gert Ossenkoppele; Pierre W Wijermans; Mark H H Kramer; Mars B van 't Veer; Harry C Schouten; Marinus van Marwijk Kooy; Marinus H J van Oers; John M M Raemaekers; Pieter Sonneveld; L A M H Meulendijks; Philip M Kluin; Hanneke C Kluin-Nelemans; Leo F Verdonck
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
Leukemia 2005;19(6):945-52.
2005: Michel van Agthoven; Pieter Sonneveld; Leo F Verdonck; Carin A Uyl-de Groot
Cost determinants in aggressive non-Hodgkin's lymphoma.
Haematologica 2005;90(5):661-71.
2005: Dimitri A Breems; Wim L J van Putten; Peter C Huijgens; Gert Ossenkoppele; Gregor Verhoef; Leo F Verdonck; Edo Vellenga; Georgine E De Greef; Emanuel Jacky; Johannes Van Der Lelie; Marc Boogaerts; Bob Löwenberg
Prognostic index for adult patients with acute myeloid leukemia in first relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1969-78.
2005: Ellen Meijer; S Spijkers; S Moschatsis; Greet J Boland; S F T Thijsen; Anton M van Loon; Leo F Verdonck
Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?
Transplant infectious disease : an official journal of the Transplantation Society 2005;7(1):4-10.
2005: Hanneke M van der Straaten; Rob Fijnheer; H Karel Nieuwenhuis; Jan G J van de Winkel; Leo F Verdonck
The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):206-12.
2005: Georgine E De Greef; Wim L J van Putten; Marc Boogaerts; Peter C Huijgens; Leo F Verdonck; Edo Vellenga; Matthias Theobald; Emanuel Jacky; Bob Löwenberg
Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies.
British journal of haematology 2005;128(2):184-91.
2005: Dimitri A Breems; Marc Boogaerts; Adriaan W Dekker; Wim L J van Putten; Pieter Sonneveld; Peter C Huijgens; Johannes Van Der Lelie; Edo Vellenga; Alois Gratwohl; Gregor Verhoef; Leo F Verdonck; Bob Löwenberg
Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial.
British journal of haematology 2005;128(1):59-65.
2004: Ellen Meijer; Adriaan W Dekker; Henk M Lokhorst; Eefke J Petersen; H Karel Nieuwenhuis; Leo F Verdonck
Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2004;6(4):171-8.
2004: Hanneke M van der Straaten; Marijke R Canninga-Van Dijk; Leo F Verdonck; Domenico Castigliego; H P Eric Borst; Jan Aten; Rob Fijnheer
Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease.
The Journal of investigative dermatology 2004;123(6):1057-62.
2004: Marijke R Canninga-Van Dijk; Hanneke M van der Straaten; Rob Fijnheer; Cornelus J G Sanders; Jan G van den Tweel; Leo F Verdonck
Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease.
Blood 2004;104(8):2603-6.
2004: S M G J Daenen; Bronno van der Holt; Gregor Verhoef; Bob Löwenberg; Pierre W Wijermans; Peter C Huijgens; Rien van Marwijk Kooy; Harry C Schouten; Mark H H Kramer; Augustin Ferrant; Eva van den Berg; Monique M C Steijaert; Leo F Verdonck; Pieter Sonneveld
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults.
Leukemia research 2004;28(10):1057-67.
2004: Henk M Lokhorst; Kalung Wu; Leo F Verdonck; Laurens Laterveer; Niels W C J van de Donk; Marinus H J van Oers; Jan J Cornelissen; A V M B Schattenberg
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma.
Blood 2004;103(11):4362-4.
2004: Gert Ossenkoppele; Wilfried J Graveland; Pieter Sonneveld; S M G J Daenen; Douwe H Biesma; Leo F Verdonck; M Ronald Schaafsma; Petra H M Westveer; Godefridus J Peters; Paul Noordhuis; Petra Muus; Dominik Selleslag; Bronno van der Holt; Michel Delforge; Bob Löwenberg; Gregor Verhoef
The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.
Blood 2004;103(8):2908-13.
2003: C M P W Mandigers; Leo F Verdonck; Jules P P Meijerink; Adriaan W Dekker; A V M B Schattenberg; John M M Raemaekers
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Bone marrow transplantation 2003;32(12):1159-63.
2003: Eefke J Petersen; H L Lokhorst; Leo F Verdonck
[Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].
Nederlands tijdschrift voor geneeskunde 2003;147(47):2328-32.
2003: Ellen Meijer; Jan J Cornelissen; Bob Löwenberg; Leo F Verdonck
Antithymocyteglobulin as prophylaxis of graft failure and graft-versus-host disease in recipients of partially T-cell-depleted grafts from matched unrelated donors: a dose-finding study.
Experimental hematology 2003;31(11):1026-30.
2003: Ellen Meijer; Greet J Boland; Leo F Verdonck
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants.
Clinical microbiology reviews 2003;16(4):647-57.
2003: Jan J Cornelissen; Bronno van der Holt; Eefke J Petersen; Lars Vindelov; Charlotte A Russel; Martin Höglund; Johan Maertens; Harry C Schouten; Eric Braakman; Monique M C Steijaert; Mark J M Zijlmans; Ineke Slaper-Cortenbach; Marc Boogaerts; Bob Löwenberg; Leo F Verdonck
A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.
Experimental hematology 2003;31(10):855-64.
2003: Bram van Kooij; S F T Thijsen; Ellen Meijer; Hubert G M Niesters; Joost W J van Esser; Jan J Cornelissen; Leo F Verdonck; Anton M van Loon
Sequence analysis of EBV DNA isolated from mouth washings and PBMCs of healthy individuals and blood of EBV-LPD patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;28(1):85-92.
2003: Bob Löwenberg; Wim L J van Putten; Matthias Theobald; Jürg Gmür; Leo F Verdonck; Pieter Sonneveld; Martin Fey; Harry Schouten; Georgine E De Greef; Augustin Ferrant; Tibor J Kovacsovics; Alois Gratwohl; S M G J Daenen; Peter C Huijgens; Marc Boogaerts
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
The New England journal of medicine 2003;349(8):743-52.
2003: Jeanette K Doorduijn; Bronno van der Holt; Gustaaf W van Imhoff; Klaas G van der Hem; Mark H H Kramer; Marinus H J van Oers; Gert Ossenkoppele; M Ronald Schaafsma; Leo F Verdonck; Gregor Verhoef; Monique M C Steijaert; Ivonne Buijt; Carin A Uyl-de Groot; Michel van Agthoven; Andries H Mulder; Pieter Sonneveld
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3041-50.
2003: Rob Fijnheer; Cornelus J G Sanders; M R Canninga; R A de Weger; Leo F Verdonck
Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation.
Bone marrow transplantation 2003;32(3):345-7.
2003: Ellen Meijer; Andries C Bloem; Adriaan W Dekker; Leo F Verdonck
Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts.
Transplantation 2003;75(11):1910-3.
2003: Saskia B Ebeling; Roman Ivanov; Samantha Hol; Tineke Aarts; Anton Hagenbeek; Leo F Verdonck; Eefke J Petersen
HLA-DRB1*16-restricted recognition of myeloid cells, including CD34+ CML progenitor cells.
British journal of haematology 2003;121(5):721-9.
2003: Henk M Lokhorst; Christine M Segeren; Leo F Verdonck; Bronno van der Holt; Reinier A P Raymakers; Marinus H J van Oers; Renée M Y Barge; Harry C Schouten; Petra H M Westveer; Monique M C Steijaert; Jan J Cornelissen; Pieter Sonneveld
Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1728-33.
2003: Ellen Meijer; Adriaan W Dekker; Leo F Verdonck
Influence of antithymocyte globulin dose on outcome in cytomegalovirus-seropositive recipients of partially T cell-depleted stem cell grafts from matched-unrelated donors.
British journal of haematology 2003;121(3):473-6.
2003: Marijke R Canninga-Van Dijk; Cornelus J G Sanders; Leo F Verdonck; Rob Fijnheer; Jan G van den Tweel
Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation.
Histopathology 2003;42(4):313-30.
2003: Laurens Laterveer; Leo F Verdonck; Ton Peeters; Erik Borst; Andries C Bloem; Henk M Lokhorst
Graft versus myeloma may overcome the unfavorable effect of deletion of chromosome 13 in multiple myeloma.
Blood 2003;101(3):1201-2.
2003: Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Claudia Erpelinck; Wim L J van Putten; Peter J M Valk; Sonja van der Poel-van de Luytgaarde; Ronald Hack; Rosalyn Slater; Elisabeth M E Smit; Berna Beverloo; Gregor Verhoef; Leo F Verdonck; Gert Ossenkoppele; Pieter Sonneveld; Georgine E De Greef; Bob Löwenberg; Ruud Delwel
High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.
Blood 2003;101(3):837-45.
2002: Ellen Meijer; Adriaan W Dekker; Annemarie J L Weersink; Maja Rozenberg-Arska; Leo F Verdonck
Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants.
British journal of haematology 2002;119(3):596-607.
2002: Ellen Meijer; Adriaan W Dekker; Maja Rozenberg-Arska; Annemarie J L Weersink; Leo F Verdonck
Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(6):703-12.
2002: Marian G J van Kraaij; Leo F Verdonck; Maja Rozenberg-Arska; Adriaan W Dekker
Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.
Bone marrow transplantation 2002;30(5):303-9.
2002: Tapani Ruutu; Jo Hermans; Dietger Niederwieser; Alois Gratwohl; Michael Kiehl; Liisa Volin; Harmut Bertz; Per Ljungman; David Spence; Leo F Verdonck; H Grant Prentice; Alberto Bosi; Cecile E Du Toit; Lorentz Brinch; Jane F Apperley
Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2002;118(4):1112-9.
2002: Michel van Agthoven; Martijn T Groot; Leo F Verdonck; Bob Löwenberg; A V M B Schattenberg; Machteld Oudshoorn; Anton Hagenbeek; Jan J Cornelissen; Carin A Uyl-de Groot; R Willemze
Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
Bone marrow transplantation 2002;30(4):243-51.
2002: Su-Jun Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; gregory alan hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.
Blood 2002;100(2):406-14.
2002: cesare guglielmi; William Arcese; Francesco Dazzi; Ronald Brand; Donald Bunjes; Leo F Verdonck; Anton Schattenberg; Hans-Jochem Kolb; Per Ljungman; Agnès Devergie; Andrea Bacigalupo; Marta Gomez; Mauricette Michallet; Ahmet H Elmaagacli; Alois Gratwohl; Jane Apperley; Dietger Niederwieser
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose.
Blood 2002;100(2):397-405.
2002: Rob Fijnheer; Birgit Paijmans; Leo F Verdonck; H Karel Nieuwenhuis; Mark Roest; Adriaan W Dekker
Factor V Leiden in central venous catheter-associated thrombosis.
British journal of haematology 2002;118(1):267-70.
2002: Joost W J van Esser; Hubert G M Niesters; Bronno van der Holt; Ellen Meijer; Albert D M E Osterhaus; Jan W Gratama; Leo F Verdonck; Bob Löwenberg; Jan J Cornelissen
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.
Blood 2002;99(12):4364-9.
2002: M Loes van Kempen-Harteveld; Henk Struikmans; Henk B Kal; Ingeborg van der Tweel; Maarten P Mourits; Leo F Verdonck; Jan Schipper; Jan J Battermann
Cataract after total body irradiation and bone marrow transplantation: degree of visual impairment.
International journal of radiation oncology, biology, physics 2002;52(5):1375-80.
2002: Ellen Meijer; Ineke Slaper-Cortenbach; S F T Thijsen; Adriaan W Dekker; Leo F Verdonck
Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
Bone marrow transplantation 2002;29(4):335-9.
2001: Arjan Buijs; P Poddighe; Richard van Wijk; Wouter W van Solinge; E Borst; Leo F Verdonck; Anton Hagenbeek; P Pearson; Henk M Lokhorst
A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.
Blood 2001;98(9):2856-8.
2001: Joost W J van Esser; Bronno van der Holt; Ellen Meijer; Hubert G M Niesters; Rudolf Trenschel; S F T Thijsen; Anton M van Loon; F Frassoni; A Bacigalupo; Ulrich W Schaefer; Albert D M E Osterhaus; Jan W Gratama; Bob Löwenberg; Leo F Verdonck; Jan J Cornelissen
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.
Blood 2001;98(4):972-8.
2001: Edo Vellenga; Michel van Agthoven; Alexandra J Croockewit; Leo F Verdonck; P J Wijermans; Marinus H J van Oers; Corine P Volkers; Gustaaf W van Imhoff; T Kingma; Carin A Uyl-de Groot; W E Fibbe
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
British journal of haematology 2001;114(2):319-26.
2001: Hanneke M van der Straaten; Rob Fijnheer; Adriaan W Dekker; H Karel Nieuwenhuis; Leo F Verdonck
Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation.
British journal of haematology 2001;114(1):31-5.
2001: Joost W J van Esser; Hubert G M Niesters; S F T Thijsen; Ellen Meijer; Albert D M E Osterhaus; K C Wolthers; C A Boucher; Jan W Gratama; L M Budel; Bronno van der Holt; Anton M van Loon; Bob Löwenberg; Leo F Verdonck; Jan J Cornelissen
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.
British journal of haematology 2001;113(3):814-21.
2001: H G Otten; A M Van Dyk; Leo F Verdonck
Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cells.
Leukemia & lymphoma 2001;40(3-4):385-91.
2000: AM van Dijk; FL Kessler; Leo F Verdonck; SA Stadhouders-Keet; RA van Lier; Gijsbert C De Gast; Henny G Otten
Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
British journal of haematology 2000;111(3):791-6.
2000: M Loes van Kempen-Harteveld; Henk Struikmans; Henk B Kal; Ingeborg van der Tweel; Maarten P Mourits; Leo F Verdonck; J Schipper; Jan J Battermann
Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters.
International journal of radiation oncology, biology, physics 2000;48(3):807-15.
2000: Roel A de Weger; Marcel G J Tilanus; KC Scheidel; Jan G van den Tweel; Leo F Verdonck
Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats.
British journal of haematology 2000;110(3):647-53.
2000: AM van Dijk; Gijsbert C De Gast; FL Kessler; SA Stadhouders-Keet; RA van Lier; Leo F Verdonck; Henny G Otten
Determination of helper T-cell precursor frequencies against non-haemopoietic cells: comparison of co-stimulation provided by anti-CD28 antibody versus the cellular ligand B7-1.
British journal of haematology 2000;110(2):322-6.
2000: Marian G J van Kraaij; Adriaan W Dekker; Leo F Verdonck; Anton M van Loon; Jan Vinjé; Marion Koopmans; Maja Rozenberg-Arska
Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients.
Bone marrow transplantation 2000;26(3):299-303.
2000: Dorina M van der Kolk; Elisabeth G E de Vries; W J van Putten; Leo F Verdonck; Gert Ossenkoppele; Gregor Verhoef; Edo Vellenga
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3205-14.
2000: Henk M Lokhorst; A V M B Schattenberg; Jan J Cornelissen; Marinus H J van Oers; Willem E Fibbe; I Russell; N W Donk; Leo F Verdonck
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):3031-7.
1999: AM van Dijk; FL Kessler; SA Stadhouders-Keet; Leo F Verdonck; Gijsbert C De Gast; Henny G Otten
Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease.
British journal of haematology 1999;107(1):169-75.
1999: Ineke Slaper-Cortenbach; M J Wijngaarden-du Bois; A de Vries-van Rossen; H P Borst; Hans van der Lelie; HG van Heugten; Leo F Verdonck; Nico M Wulffraat; P M Hoogerbrugge
The depletion of T cells from haematopoietic stem cell transplants.
Rheumatology (Oxford, England) 1999;38(8):751-4.
1999: Gert Ossenkoppele; Bronno van der Holt; Gregor Verhoef; S M G J Daenen; Leo F Verdonck; Pieter Sonneveld; Pierre W Wijermans; Johannes Van Der Lelie; Wim L J van Putten; Bob Löwenberg
A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative Group.
Leukemia 1999;13(8):1207-13.
1999: Henk M Lokhorst; Pieter Sonneveld; Leo F Verdonck
Intensive treatment for multiple myeloma: where do we stand?
British journal of haematology 1999;106(1):18-27.
1999: Edo Vellenga; Wim L J van Putten; Marc Boogaerts; S M G J Daenen; Gregor Verhoef; Anton Hagenbeek; Andries R Jonkhoff; Peter C Huijgens; Leo F Verdonck; Johannes Van Der Lelie; Harry C Schouten; Jürg Gmür; Pierre W Wijermans; Alois Gratwohl; U Hess; M F Fey; Bob Löwenberg
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
Bone marrow transplantation 1999;23(12):1279-82.
1999: Leo F Verdonck
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience.
Leukemia & lymphoma 1999;34(1-2):129-36.
1999: RM van der Plas; Marion E Schiphorst; Eric G Huizinga; Ronald J Hené; Leo F Verdonck; Jan J Sixma; Rob Fijnheer
von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura.
Blood 1999;93(11):3798-802.
1999: G J Boonen; AM van Dijk; Leo F Verdonck; RA van Lier; Gert Rijksen; René H Medema
CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
European journal of immunology 1999;29(3):789-98.
1999: Henk M Lokhorst; Pieter Sonneveld; Jan J Cornelissen; Peter Joosten; Marinus van Marwijk Kooy; J Meinema; H Karel Nieuwenhuis; Marinus H J van Oers; D J Richel; C N Segeren; G Veth; Leo F Verdonck; Pierre W Wijermans
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
Bone marrow transplantation 1999;23(4):317-22.
1999: René van der Griend; Leo F Verdonck; Eefke J Petersen; P Veenhuizen; Andries C Bloem; Henk M Lokhorst
Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.
Bone marrow transplantation 1999;23(2):195-7.
1998: Leo F Verdonck; Eefke J Petersen; Henk M Lokhorst; H Karel Nieuwenhuis; Adriaan W Dekker; Marcel G J Tilanus; Roel A de Weger
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
Bone marrow transplantation 1998;22(11):1057-63.
1998: P Ellerbroek; S Kuipers; Maja Rozenberg-Arska; Leo F Verdonck; Eefke J Petersen
Oerskovia xanthineolytica: a new pathogen in bone marrow transplantation.
Bone marrow transplantation 1998;22(5):503-5.
1998: Koen van Besien; Kathleen A Sobocinski; Philip Rowlings; S C Murphy; James O Armitage; Michael Bishop; O K Chaekal; Robert Peter Gale; John P Klein; Hillard M Lazarus; Philip L McCarthy; John M M Raemaekers; J Reiffers; Gordon L Phillips; A V M B Schattenberg; Leo F Verdonck; Julie M Vose; Mary M Horowitz
Allogeneic bone marrow transplantation for low-grade lymphoma.
Blood 1998;92(5):1832-6.
1998: Marian G J van Kraaij; Adriaan W Dekker; E Peters; A Fluit; Leo F Verdonck; Maja Rozenberg-Arska
Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(8):591-2.
1998: Jan J Cornelissen; Willem E Fibbe; A V M B Schattenberg; Eefke J Petersen; Rein Willemze; Theo de Witte; Bob Löwenberg; Leo F Verdonck; A vd Biezen; Ronald Brand
A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;21 Suppl 3():S66-70.
1998: Leo F Verdonck; Henk M Lokhorst; D J Roovers; HG van Heugten
Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunorubicin: implications for liposome-encapsulated daunorubicin.
Leukemia research 1998;22(3):249-56.
1997: Bob Löwenberg; Marc Boogaerts; S M G J Daenen; Gregor Verhoef; Anton Hagenbeek; Edo Vellenga; Gert Ossenkoppele; Peter C Huijgens; Leo F Verdonck; Johannes Van Der Lelie; JJ Wielenga; Harry C Schouten; Jürg Gmür; Alois Gratwohl; U Hess; M F Fey; Wim L J van Putten
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3496-506.
1997: Henk M Lokhorst; A V M B Schattenberg; Jan J Cornelissen; L L Thomas; Leo F Verdonck
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation.
Blood 1997;90(10):4206-11.
1997: Leo F Verdonck; Adriaan W Dekker; Henk M Lokhorst; Eefke J Petersen; H Karel Nieuwenhuis
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
Blood 1997;90(10):4201-5.
1997: Leo F Verdonck; Adriaan W Dekker; Maja Rozenberg-Arska; M R van den Hoek
A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):901-7.
1997: D H Biesma; J G van den Tweel; Leo F Verdonck
Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
Cancer 1997;79(8):1548-51.
1997: H van Ojik; Douwe H Biesma; Rob Fijnheer; Ronald J Hené; Henk M Lokhorst; S J Rooda; Leo F Verdonck
Cyclosporin for thrombotic thrombocytopenic purpura after autologous bone marrow transplantation.
British journal of haematology 1997;96(3):641-3.
1997: Adriaan W Dekker; Mars B van't Veer; W Sizoo; H L Haak; Johannes Van Der Lelie; Gert Ossenkoppele; Peter C Huijgens; Harry C Schouten; Pieter Sonneveld; Rein Willemze; Leo F Verdonck; Wim L J van Putten; Bob Löwenberg
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):476-82.
1997: Bob Löwenberg; Wim L J van Putten; A Ferrant; Gert Ossenkoppele; Edo Vellenga; Leo F Verdonck; A Gratwohl; M A Boogaerts
Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia.
Stem cells (Dayton, Ohio) 1997;15 Suppl 1():177-80; discussion 181.
1997: Leo F Verdonck; HG van Heugten
Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosis.
Leukemia research 1997;21(1):37-43.
1996: Eefke J Petersen; Maja Rozenberg-Arska; Adriaan W Dekker; Hans Clevers; Leo F Verdonck
Allogeneic bone marrow transplantation can restore CD4+ T-lymphocyte count and immune function in idiopathic CD4+ T-lymphocytopenia.
Bone marrow transplantation 1996;18(4):813-5.
1996: Leo F Verdonck; W T van Blokland; E K Bosboom-Kalsbeek; H G van Heugten; M G Tilanus; Roel A de Weger
Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
Bone marrow transplantation 1996;18(2):389-95.
1996: Leo F Verdonck; Henk M Lokhorst; Adriaan W Dekker; H Karel Nieuwenhuis; Eefke J Petersen
Graft-versus-myeloma effect in two cases.
Lancet 1996;347(9004):800-1.
1995: E C Heesbeen; Gert Rijksen; H G van Heugten; Leo F Verdonck
Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3.
Leukemia research 1995;19(6):417-25.
1994: Adriaan W Dekker; Leo F Verdonck; Maja Rozenberg-Arska
Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
Bone marrow transplantation 1994;14(1):89-93.
1994: Leo F Verdonck; Adriaan W Dekker; Gijsbert C De Gast; M L van Kempen; Henk M Lokhorst; H Karel Nieuwenhuis
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft.
Blood 1994;83(10):3090-6.
1994: E C Heesbeen; Leo F Verdonck; G E Staal; Gert Rijksen
Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells.
Biochemical pharmacology 1994;47(9):1481-8.
1993: John M M Raemaekers; Gustaaf W van Imhoff; Leo F Verdonck; J A Hessels; Willem E Fibbe
The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma. A phase-I study.
Annals of hematology 1993;67(4):175-81.
1993: Mars B van't Veer; Wim L J van Putten; Leo F Verdonck; Gert Ossenkoppele; Bob Löwenberg; Johanna C Kluin-Nelemans; P W Wijermans; Harry C Schouten; W Sizoo; Adriaan W Dekker
Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentation.
Annals of hematology 1993;66(6):277-82.
1993: E C Heesbeen; Leo F Verdonck; M Haagmans; H G van Heugten; G E Staal; Gert Rijksen
Adsorption and uptake of the alkyllysophospholipid ET-18-OCH3 by HL-60 cells during induction of differentiation by dimethylsulfoxide.
Leukemia research 1993;17(2):143-8.
1993: Leo F Verdonck; J J Cornelissen; J Smit; J Lepoutre; Gijsbert C De Gast; Adriaan W Dekker; Maja Rozenberg-Arska
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Bone marrow transplantation 1993;11(2):177-9.
1992: Leo F Verdonck; Adriaan W Dekker; Gijsbert C De Gast; M L van Kempen; Henk M Lokhorst; H Karel Nieuwenhuis
Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1949-54.
1992: Leo F Verdonck; E C Heesbeen; H G van Heugten; G E Staal; Gert Rijksen
The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Bone marrow transplantation 1992;9(4):241-5.
1992: Leo F Verdonck; Adriaan W Dekker; Gijsbert C De Gast; Henk M Lokhorst; H Karel Nieuwenhuis
Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):644-6.
1991: E C Heesbeen; Leo F Verdonck; S W Hermans; H G van Heugten; G E Staal; Gert Rijksen
Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cells.
FEBS letters 1991;290(1-2):231-4.
1991: Leo F Verdonck; Gijsbert C De Gast; H G van Heugten; H Karel Nieuwenhuis; Adriaan W Dekker
Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation.
Blood 1991;78(3):844-8.
1991: Leo F Verdonck; H G van Heugten; J Giltay; C R Franks
Amplification of the graft-versus-leukemia effect in man by interleukin-2.
Transplantation 1991;51(5):1120-4.
1990: Leo F Verdonck; E O Witteveen; H G van Heugten; E Rozemuller; Gert Rijksen
Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
Cancer research 1990;50(13):4020-5.
1990: Adriaan W Dekker; H K Nieuwenhuis; Leo F Verdonck
Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemia.
Cancer 1990;65(9):1891-4.
1990: Leo F Verdonck; Gijsbert C De Gast; H G van Heugten; Adriaan W Dekker
A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation.
Blood 1990;75(3):776-80.
1990: Leo F Verdonck; Gijsbert C De Gast; H G van Heugten; Adriaan W Dekker
Bone marrow transplantation with a fixed low number of T-cells in the graft.
Haematology and blood transfusion 1990;33():707-8.
1990: Adriaan W Dekker; M Rozenberg-Arska; Leo F Verdonck
Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment.
Haematology and blood transfusion 1990;33():551-4.
1990: E O Witteveen; Leo F Verdonck; H K Nieuwenhuis; Adriaan W Dekker
Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
Haematology and blood transfusion 1990;33():309-13.
1990: B Löwenberg; Wim L J van Putten; Leo F Verdonck; Adriaan W Dekker; G C de Gast; R Willemze; F E Zwaan; J Abels; Pieter Sonneveld; J van der Lelie
Autologous bone marrow transplantation in acute myeloid leukemia in first remission: first Dutch prospective study.
Haematology and blood transfusion 1990;33():655-60.
1989: Y C de Graan-Hentzen; J W Gratama; Geert Mudde; Leo F Verdonck; J G Houbiers; A Brand; F W Sebens; A M van Loon; T H The; R Willemze
Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products.
Transfusion 1989;29(9):757-60.
1989: Gijsbert C De Gast; J W Gratama; Leo F Verdonck; J G van Heugten; F E Zwaan; D I Phillips; Geert Mudde
The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation.
Transplantation 1989;48(1):111-5.
1989: Leo F Verdonck; Gijsbert C De Gast; Adriaan W Dekker; Roel A de Weger; H J Schuurman; Maja Rozenberg-Arska
Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Bone marrow transplantation 1989;4(2):187-9.
1988: Leo F Verdonck; Gijsbert C De Gast; J M Lange; H J Schuurman; Adriaan W Dekker; bert bast
Syngeneic leukocytes together with suramin failed to improve immunodeficiency in a case of transfusion-associated AIDS after syngeneic bone marrow transplantation.
Blood 1988;71(3):666-71.
1987: Leo F Verdonck; Adriaan W Dekker; P J Vendrik; M L van Kempen; Jan Schornagel; M Rozenberg-Arska; G C de Gast
Intensive cytoreductive therapy followed by autologous bone marrow transplantation for patients with hematologic malignancies or solid tumors.
Cancer 1987;60(3):289-95.
1987: Leo F Verdonck; Y C de Graan-Hentzen; Adriaan W Dekker; Geert Mudde; Gijsbert C De Gast
Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
Bone marrow transplantation 1987;2(1):73-8.
1987: Adriaan W Dekker; K Punt; Leo F Verdonck
The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia.
Haematology and blood transfusion 1987;30():333-5.
1987: Leo F Verdonck; Adriaan W Dekker; H van Heugten; M L van Kempen; K Punt; Gijsbert C De Gast
Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.
Haematology and blood transfusion 1987;30():563-6.
1986: J W Gratama; Leo F Verdonck; J A van der Linden; J G van Heugten; H A Kreeft; Joseph D'Amaro; F E Zwaan; Gijsbert C De Gast
Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
Transplantation 1986;41(6):719-24.
1985: Gijsbert C De Gast; Leo F Verdonck; Jaap Middeldorp; T H The; A Hekker; J A vd Linden; H A Kreeft; bert bast
Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft.
Blood 1985;66(2):428-31.
1985: Leo F Verdonck; Adriaan W Dekker; M L van Kempen; K Punt; J A van Unnik; H A van Peperzeel; Gijsbert C De Gast
Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non-Hodgkin's lymphoma of high-grade malignancy.
Blood 1985;65(4):984-9.
1985: Leo F Verdonck; Jaap Middeldorp; H A Kreeft; T H The; A Hekker; Gijsbert C De Gast
Primary cytomegalovirus infection and its prevention after autologous bone marrow transplantation.
Transplantation 1985;39(4):455-7.